Institution
Marqués de Valdecilla University Hospital
Also known as: Hospital Universitario Marqués de Valdecilla · Valdecilla · HUMV
- 437running trials
- 218closed trials
- 18,169publications (OpenAlex)
Running trials
Not yet recruiting
Not yet recruiting
Pembrolizumab Plus Belzutifan With or Without Lenvatinib in Localized Renal Cell Carcinoma
Not yet recruiting
Not yet recruiting
Not yet recruiting
Not yet recruiting
A Phase 2 trial of AGMB-447 in participants with idiopathic pulmonary fibrosis
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Clinical Trial of NS-863 in Participants With Pulmonary Arterial Hypertension (PAH)
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Radium-223 for High-Volume Metastatic Hormone Sensitive Prostate Cancer
Not yet recruiting
Not yet recruiting
A study to learn about the effects of Trontinemab in participants at risk for Alzheimer‘s disease
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Not yet recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Showing 50 of 437.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Bladder cancer17 recruiting
- Colorectal cancer16 recruiting
- Multiple myeloma16 recruiting
- Lung cancer13 recruiting
- Chronic lymphocytic leukaemia12 recruiting
- Childhood cancers11 recruiting
- Prostate cancer11 recruiting
- High blood pressure10 recruiting
- Idiopathic pulmonary fibrosis10 recruiting
- Fatty liver disease (MASLD/MASH)9 recruiting
- Type 2 diabetes9 recruiting
- Acute lymphoblastic leukaemia8 recruiting
- Gastric and oesophageal cancer8 recruiting
- Obesity8 recruiting
- Pancreatic cancer8 recruiting
- Pulmonary arterial hypertension8 recruiting
- Head and neck cancer7 recruiting
- Liver and biliary tract cancer7 recruiting
- Asthma6 recruiting
- Lupus (SLE)6 recruiting
- Acute myeloid leukaemia5 recruiting
- COPD5 recruiting
- Coronary artery disease5 recruiting
- Kidney cancer5 recruiting
- Liver cirrhosis5 recruiting
- Melanoma5 recruiting
- Metastatic breast cancer5 recruiting
- Stroke5 recruiting
- Alzheimer disease4 recruiting
- Diffuse large B-cell lymphoma4 recruiting
- Follicular lymphoma3 recruiting
- HIV3 recruiting
- Neuroendocrine tumours3 recruiting
- Osteoarthritis3 recruiting
- Ovarian cancer3 recruiting
- Primary biliary cholangitis3 recruiting
- Bronchiectasis2 recruiting
- Chronic kidney disease2 recruiting
- Chronic rhinosinusitis with nasal polyps2 recruiting
- Crohn's disease2 recruiting
- Cytomegalovirus infection2 recruiting
- Deep vein thrombosis and pulmonary embolism2 recruiting
- Down syndrome2 recruiting
- Heart failure2 recruiting
- Mantle cell lymphoma2 recruiting
- Psoriasis2 recruiting
- Psoriatic arthritis2 recruiting
- Sjögren's disease2 recruiting
- Triple-negative breast cancer2 recruiting
- Ankylosing spondylitis1 recruiting
- Aortic stenosis1 recruiting
- Atrial fibrillation1 recruiting
- Brain aneurysm1 recruiting
- Brain metastases1 recruiting
- Cervical cancer1 recruiting
- Depression1 recruiting
- Endometrial cancer1 recruiting
- Epilepsy1 recruiting
- Graves' disease1 recruiting
- Hodgkin lymphoma1 recruiting
- Multiple sclerosis1 recruiting
- Obstructive sleep apnoea1 recruiting
- Parkinson disease1 recruiting
- Rheumatoid arthritis1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Thyroid cancer1 recruiting
- Type 1 diabetes1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Active, not recruiting
Completed
Terminated
Refractory Advanced diGestive Neuroendocrine Carcinomas Treated With tARlatamab
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
Completed
Completed
Active, not recruiting
Completed
Completed
Completed
A Study of Maribavir in Adults With Post-transplant Cytomegalovirus (CMV) Infection
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
A Retrospective Chart Review Study of Patients With CLAD-BOS Post Lung Transplantation
Completed
Completed
Completed
Completed
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
Completed
Completed
Completed
Completed
VH4524184 Proof-of-Concept in Treatment-Naïve Adults Living With HIV-1
Completed
Completed
Completed
A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD
Completed
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Active, not recruiting
MAXPIRe: Study to Evaluate Axatilimab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
Prevalence and Risk Factors for Postoperative Delirium 48 Hours After Surgery
Completed
Development of a Molecular Diagnostic Tool for Endometrial Cancer.
Terminated
Completed
Completed
Completed
Completed
Showing 50 of 218.
Registry name variants (60)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Hospital Universitario Marqués de Valdecilla
Santander, 39008
618 trials
Hosp. Univ. Marques de Valdecilla
Santander, 39008
13 trials
Marqués de Valdecilla University Hospital
Santander, 39011
5 trials
Hospital Universitario Marques de Valdecilla (HUMV)
Santander, 39008
4 trials
University Hospital Marques de Valdecilla (HUMV)
Santander, Cantabria 39008
2 trials
Contact: Marta Francisca Lopez-Brea Piqueras, Dr.
7240068 - Hospital Universitario Marqués de Valdecilla
Santander, 39010
1 trial
Hospital Universitario Marqués de Valdecilla (Adults and Pediatrics)
Santander, Cantabria 39008
1 trial
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
1 trial
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
1 trial
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
1 trial
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
1 trial
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
1 trial
Hospital Universitario Marqués de Valdecilla (Santander)
Santander, Cantabria 39008
1 trial
Hospital Universitario Marques de Valdecilla (Site 0181)
Santander, Cantabria 39008
1 trial
Hospital Universitario Marqués de Valdecilla (Site 1201)
Santander, Cantabria 39008
1 trial
Hospital Universitario Marques de Valdecilla (Site 1602)
Santander, Cantabria 39008
1 trial
Hospital Universitario Marques de Valdecilla (Site 1804)
Santander, Cantabria 39008
1 trial
Hospital Universitario Marques de Valdecilla (Site 1825)
Santander, Cantabria 39008
1 trial
NCT07060807A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Contact: Study Coordinator
Hospital Universitario Marques de Valdecilla (Site 1902)
Santander, Cantabria 39008
1 trial
IDIVAL/University Hospital Marques de Valdecilla
Santander
1 trial
Marques de Valdecilla University Hospital (HUMV)
Santander, 39008
1 trial
Neurology Service: Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
1 trial
Universidad de Cantabria (UC) - Hospital Universitario Marques de Valdecilla (HUMV)
Santander, Cantabria 39008
1 trial
Contact: Marta Sotelo
University Hospital Marqués de Valdecilla
Santander, 39008
1 trial
University Hospital of Hospital Marqués de Valdecilla
Santander, 39008
1 trial
Hospital Universitario Marqués del Valdecilla
Santander, 39008
Hospital Universitario Marqués de Valdecilla
Santader, 39008
Hospital Universitario Marqués de Valdecilla
Valdecilla
Hospital Universitario Marques de Valdecilla (HUMV) (Site #1309)
Santander, 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla - Servicio de Reumatologia
Santander
Hospital Universitario Marques de Valdecilla (Site 0605)
Santander, Cantabria 39008
Hospital Universitario Marqués de Valdecilla (Site 0810)
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla (Site 1003)
Santander, Cantabria 39008
Hospital Universitario Marqués de Valdecilla (Site 1202)
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla (Site 1405)
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla (Site 1501)
Santander, Cantabria 39008
Hospital Universitario Marqués de Valdecilla (Site 1551)
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla (Site 1601)
Santander, Cantabria 39008
Hospital Universitario Marqués de Valdecilla (Site 1805)
Santander, Cantabria 39008
Hospital Universitario Marqués de Valdecilla (Site 1807)
Santander, Cantabria 39008
Hospital Universitario Marqués de Valdecilla (Site 1901)
Santander, Cantabria 39008
Hospital Universitario Marqués de Valdecilla (Site 1906)
Santander, Cantabria 39008
Hospital Universitario Marques de Valdecilla - Site #560
Santander, 39008
Hospital Universitario Marques De Valdecilla - Urologia
Santander, Cantabria 39008
Conditions
Diseases this institution publishes on or runs trials for.
- Crohn's disease33 works · 10 trials
- Lupus (SLE)30 works · 15 trials
- Fatty liver disease (MASLD/MASH)27 works · 21 trials
- Ulcerative colitis24 works · 8 trials
- Antiphospholipid syndrome12 works · 0 trials
- Long COVID and ME/CFS9 works · 0 trials
- Giant cell arteritis7 works · 3 trials
- Hidradenitis suppurativa6 works · 0 trials
- ANCA-associated vasculitis4 works · 1 trial
- Charcot-Marie-Tooth disease3 works · 0 trials
Institution data: ROR 01w4yqf75 (CC0-1.0)Updated 15 Nov 2026